Eli Lilly and Company in the United States developed and produced selpercatinib. The specification of selpercatinib is 40mg/120 capsules, and the price is approximately $662. There are various manufacturers of selpercatinib, and prices vary depending on the manufacturer, selpercatinib, and sales channels, and are influenced by multiple factors.
Selpercatinib is a targeted therapy for specific gene mutations (such as RET fus···【more】
Release date:2026-02-27Recommended:115
Selpercatinib is a targeted therapy designed for specific gene mutations (such a···【more】
Release date:2026-02-27Recommended:95
Serpatinib is an important drug, and its application in the medical field has at···【more】
Release date:2024-12-24Recommended:276
Serpatinib is an important therapeutic drug, and its price, side effects and sid···【more】
Release date:2024-12-23Recommended:290
With the rapid development of medical technology, new drugs are emerging, among ···【more】
Release date:2024-12-23Recommended:267
Serpatinib is an important drug, and its price and precautions in the process of···【more】
Release date:2024-12-23Recommended:294
As a RET gene-targeted drug, Selpercatinib can effectively treat RET-related can···【more】
Release date:2024-08-15Recommended:317
Serpatinib is an innovative cancer treatment that targets mutations in the RET g···【more】
Release date:2024-08-15Recommended:344
Selpercatinib has a significant effect on RET-mutated cancers, especially in the···【more】
Release date:2024-08-15Recommended:335